- Home
- NURO vs HOTH Comparison
NURO vs HOTH Comparison
Compare NURO & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- HOTH
- Stock Information
- Founded
- NURO 1996
- HOTH 2017
- Country
- NURO United States
- HOTH United States
- Employees
- NURO N/A
- HOTH N/A
- Industry
- NURO Medical/Dental Instruments
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- NURO Health Care
- HOTH Health Care
- Exchange
- NURO Nasdaq
- HOTH Nasdaq
- Market Cap
- NURO 7.6M
- HOTH 7.6M
- IPO Year
- NURO N/A
- HOTH 2019
- Fundamental
- Price
- NURO $3.93
- HOTH $0.80
- Analyst Decision
- NURO
- HOTH Strong Buy
- Analyst Count
- NURO 0
- HOTH 4
- Target Price
- NURO N/A
- HOTH $4.75
- AVG Volume (30 Days)
- NURO 21.2K
- HOTH 1.0M
- Earning Date
- NURO 11-05-2024
- HOTH 11-12-2024
- Dividend Yield
- NURO N/A
- HOTH N/A
- EPS Growth
- NURO N/A
- HOTH N/A
- EPS
- NURO N/A
- HOTH N/A
- Revenue
- NURO $3,767,764.00
- HOTH N/A
- Revenue This Year
- NURO N/A
- HOTH N/A
- Revenue Next Year
- NURO N/A
- HOTH N/A
- P/E Ratio
- NURO N/A
- HOTH N/A
- Revenue Growth
- NURO N/A
- HOTH N/A
- 52 Week Low
- NURO $2.66
- HOTH $0.58
- 52 Week High
- NURO $4.73
- HOTH $1.73
- Technical
- Relative Strength Index (RSI)
- NURO 45.39
- HOTH 45.88
- Support Level
- NURO $3.56
- HOTH $0.83
- Resistance Level
- NURO $3.80
- HOTH $0.90
- Average True Range (ATR)
- NURO 0.30
- HOTH 0.08
- MACD
- NURO -0.03
- HOTH -0.00
- Stochastic Oscillator
- NURO 37.75
- HOTH 3.10
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.